Appendix B: Sources of evidence considered by the Committee

Appendix B: Sources of evidence considered by the Committee

A The assessment report for this appraisal was prepared by the School of Health and Related Research, University of Sheffield:

  • Stevenson M, Gomersall T, Lloyd Jones M et al. Percutaneous vertebroplasty and percutaneous balloon kyphoplasty for the treatment of osteoporotic vertebral fractures: a systematic review and cost-effectiveness analysis. August 2012

B The following organisations accepted the invitation to participate in this appraisal as consultees and commentators. They were invited to comment on the draft scope, assessment report and the appraisal consultation document (ACD). Organisations listed in I and II were also invited to make written submissions and have the opportunity to appeal against the final appraisal determination.

I Manufacturers/sponsors:

  • Cook Medical

  • Johnson and Johnson

  • Medtronic

  • Stryker-Howmedica-Osteonics

II Professional/specialist and patient/carer groups:

  • Action on Pain

  • British Association of Spinal Surgeons

  • British Society of Interventional Radiology

  • British Society of Skeletal Radiology

  • Chartered Society of Physiotherapy

  • National Osteoporosis Society

  • Royal College of Nursing

  • Royal College of Physicians

  • Royal College of Radiologists

  • Society and College of Radiographers

III Other consultees:

  • Department of Health

  • Welsh Government

IV Commentator organisations (without the right of appeal):

  • Commissioning Support Appraisals Service

  • Healthcare Improvement Scotland

C The following individuals were selected from clinical specialist and patient expert nominations from the non-manufacturer/sponsor consultees and commentators. They participated in the Appraisal Committee discussions and provided evidence to inform the Appraisal Committee's deliberations. They gave their expert personal view on percutaneous vertebroplasty and percutaneous balloon kyphoplasty by attending the initial Committee discussion and/or providing written evidence to the Committee. They are invited to comment on the ACD.

  • Dr Nicola Peel, Consultant in Metabolic Bone Medicine, Sheffield Teaching Hospitals NHS Foundation Trust, nominated by the National Osteoporosis Society – clinical specialist

  • Dr Richard Whitehouse, Consultant Radiologist, Guidance and development of diagnostic and interventional musculoskeletal procedures, nominated by the British Society of Skeletal Radiology – clinical specialist

  • Christine Sharp, nominated by the National Osteoporosis Society – patient expert

  • Rick Tame, Helpline Nurse, nominated by the National Osteoporosis Society – patient expert

D Representatives from the following manufacturers/sponsors attended Committee meetings. They contributed only when asked by the Committee chair to clarify specific issues and comment on factual accuracy.

  • Johnson and Johnson

  • Medtronic

  • Stryker-Howmedica-Osteonics

  • National Institute for Health and Care Excellence (NICE)